Cost Is the Focus as Data Make Broader Case for Weight-Loss DrugsThe Outlook for Weight-Loss Drugs Just Got 'Turbocharged.' It's Good for Eli Lilly, Novo Nordisk. - Barrons - Barron's
barrons.comSubmitted by barrons9707 in news
The latest trial results confirm that the Novo Nordisk weight-loss drug Wegovy can cut the risk of strokes and heart attacks.